GPD2 and neoplasm: The KEGG signaling pathway enrichment results also indicated that isoscopoletin might play an anti-tumor role by affecting the core targets of glycolysis pathway, such as GPD2, GPI, Hsp90AA1 and PGK2, which were the intersection of most glycolysis-related pathways.